BFlow S.L. will participate in BioEurope Spring 2026, a premier partnering event for the global biotechnology and life sciences industry, to be held in Lisbon, Portugal.

BioEurope Spring brings together leading biotech and pharmaceutical companies, investors and research institutions from around the world. The event is recognized for facilitating high-value one-to-one meetings, fostering strategic partnerships, and driving innovation across the life sciences sector.

BFlow’s participation reflects its commitment to expanding its international network and strengthening collaborations within the biomedical ecosystem. During the event, the company will present its advanced organ-on-chip technology, designed to enhance preclinical research by providing more predictive and physiologically relevant in vitro models. By leverging microfluidic systems, BFlow aims to contribute to more efficient drug development processes, reducing costs and improving translational success rates.

Attending BioEurope Spring 2026 represents a strategic opportunity for BFlow to connect with potential partners, investors, and industry leaders, while showcasing its role in advancing next-generation preclinical solutions.